Forth Tx Receives Investment from Sofinnova Partners

Forth Tx Receives Investment from Sofinnova Partners

Forth Therapeutics, an Edinburgh, Scotland, and Cambridge, England, UK-based biotechnology company advancing next-generation precision therapeutics for fibrosis, launched with a funding of undisclosed amount. Backers included Sofinnova Partners, and Old College Capital. Forth Tx builds on research from Professor Neil Henderson, a world-renowned fibrosis and tissue regeneration expert. The company, which spun out of the […] The post Forth Tx Rece…

Sofinnova expands biotech accelerator strategy out of Italy with €165m Fund II close

European life sciences investor Sofinnova Partners has sealed a €165m final close for its second Biovelocita fund, targeting biotech acceleration deals. The post Sofinnova expands biotech accelerator strategy out of Italy with €165m Fund II close appeared first on AltAssets Private Equity News.